Advertisement
Indian
Serum Institute gets approval to resume India trial of AstraZeneca COVID vaccine: source
AstraZeneca has resumed British clinical trials of the vaccine, one of the most advanced in development for COVID-19, after they were paused earlier this month following a serious side effect in a trial participant.
Trials have also resumed in Brazil and South Africa, but remain on hold in the United States.Indian regulators had allowed Serum’s trials of the AstraZeneca vaccine to resume under certain conditions, including increased safety monitoring and informing volunteers about new findings, a DCGI source said.
RBI chief says India’s recovery not entrenched, will only be gradual
“High frequency indicators of agricultural activity, the purchasing managers index and certain private estimates on unemployment point to some stabilisation of economic activity in the second quarter of the current year,” Das told members of the Federation of Indian Chambers of Commerce & Industry’s national executive committee.
Some Indian hospitals scramble for oxygen as coronavirus cases top 5 million
At least 6% of India’s nearly 1 million active cases need oxygen support, health ministry official Rajesh Bhushan told reporters. Supplies were adequate but state governments should monitor usage and flag shortages, he said.
“The problem happens when at a facility level, if there is no inventory management. Every state should ensure this,” Bhushan said.
Despite market volatility, LIC made Rs 13k cr profit in equity till Aug: MD
“The insurance industry had lost about Rs 45,000 crore in new and renewable premiums in the last fortnight of FY20 due to the Covid-19 pandemic. However, we have recovered well since unlocking and registered healthy growth,” LICI Managing Director Raj Kumar said at a webinar organised by Merchants’ Chamber of Commerce and Industry.
He further said, “The market now has recovered by 32 per cent from the March lows. LIC has booked a profit of Rs 13,000 crore from equity operation and is still a net investor of Rs 28,000 crore in the market.”
International
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Advertisement
Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
